Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Navigating Regulatory Challenges – Top 10 Most Important Advisor Questions

March 14, 2024 |  

This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences sectors.

Dive into essential insights with our ‘Top 10 Most Important Advisor Questions’ series. This quick video covers Tip #9, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences sectors.

See the full video here: https://www.youtube.com/watch?v=HFznqQJzUY4

Local or National Regulatory Issues
Explore the regulatory, pricing, or market access challenges that could impact your brand in various markets. Discuss these challenges with your advisors to strategize overcoming hurdles and understand the logistics of entering new markets, whether mature or emerging.

For more questions you should be asking your advisors, check out our blog: https://www.impetusdigital.com/2020/02/03/top-10-most-important-advisor-questions/

Discover more insights and strategies for tackling challenges in Pharma and Life Sciences across our video series. Learn how Impetus Digital’s innovative platform and services can bolster your strategic objectives.

Stay connected for more updates and insights:

Visit our website: impetusdigital.com
Book a demo: meetwithimpetus.com/

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Health IT and Clinical Informatics for Improving Patient Care

Dr. Donald Rucker, National Coordinator at the Office of the National Coordinator for Health Information Technology (ONC Health IT), explores all things medical and clinical informatics and “Health IT.” Among other...

Delphi Technique Virtual Co-creation: A Customer Story

How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints.

Importance of Emotional Intelligence in Pharma and Medical Affairs

Emma Lynch, Founder of EQ Vibration & Quadrant 2 Medical, delves into a number of interesting topics such as the importance of emotional intelligence, patient-centric solutions, and adopting a growth...

Artificial Intelligence for Identifying and Monitoring Cognitive Decline

Liam Kaufman, CEO & Co-founder of Winterlight Labs, joins Natalie Yeadon, Co-owner & Managing Director at Impetus Digital, for this live Fireside Chat. Today, we are exploring a range of topics...

Impact of the Pandemic on Medical and Scientific Affairs

Dr. Shurjeel Choudhri, SVP and Head, Medical and Scientific Affairs at Bayer Canada, dives into a range of hot topics, from innovative digital technologies and beyond-the-pill medicine to the concept of patient-centricity....

Patient Partnerships: Challenges and Opportunities for Pharma

Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders, joins Natalie Yeadon, Co-owner & Managing Director at Impetus Digital, for this live Fireside Chat. Today, we are exploring...

Top 10 Tips for Creating Company Culture in a Virtual World

Remote work is here to stay. Learn how companies and employees can thrive in this new environment

Strategies to Launch and Commercialize Healthcare Innovations

Dr. Roxie Mooney, Healthcare Commercialization Strategist at Legacy DNA and best-selling author, joins Natalie Yeadon, Co-owner & Managing Director at Impetus Digital. We are discussing all things healthcare innovation and commercialization,...

Patient-Centered Digital Transformation

Lygeia Ricciardi, Advisor at Carium, joins Natalie Yeadon, Co-Founder & CEO at Impetus Digital in this Fireside Chat. They explore a variety of topics related to patient-centric care, digital health transformation,...

Effects of the Pandemic on Evidence Generation & Scientific Exchange

Farah Husein, Director, Evidence Generation, Canadian Centre of Excellence, at Takeda, discusses all things evidence generation, including the impact of the COVID-19 pandemic on HEOR, RWE, epidemiology, and PRO studies and...